A diabetic retinopathy specialist is the eye doctor — usually a retina-trained ophthalmologist — who diagnoses, monitors, and treats the eye damage caused by diabetes. Modern care combines high-resolution imaging with injection-based and surgical treatments that can preserve vision even when retinopathy is advanced. Knowing who does what, when to refer, and what to expect at each visit helps people with diabetes get to the right specialist at the right time.
Who Treats Diabetic Retinopathy
| Provider | Training | Role |
|---|---|---|
| Optometrist (OD) | 4-year optometry degree | Routine exams, screening, glasses, referral when retinopathy is found |
| General Ophthalmologist (MD/DO) | Medical school + ophthalmology residency | Comprehensive eye care, basic retinopathy management, cataract surgery |
| Medical Retina Specialist | Ophthalmology + medical retina fellowship | Anti-VEGF injections, laser, advanced imaging, macular edema |
| Vitreoretinal Surgeon | Ophthalmology + surgical retina fellowship | Vitrectomy, retinal detachment repair, complex cases |
| Endocrinologist / Primary Care | Internal medicine, often endocrine fellowship | Coordinates A1C, blood pressure, lipid control; does not treat the eye directly |
When to See a Specialist
Routine Screening Schedule
- At diagnosis of type 2 diabetes — first dilated exam within 1 month
- Within 5 years of type 1 diabetes diagnosis
- Annually or every 1 to 2 years thereafter if no retinopathy is found
- Every trimester during pregnancy if pre-existing diabetes
Earlier or More Frequent Referral
- Any retinopathy found on screening
- New blurry vision unrelated to glasses
- Floaters, flashes, or a curtain in the field of vision
- Sudden vision loss (same-day evaluation or ER)
- Difficulty controlling diabetes or rapid A1C drops
- Pregnancy planning
What an Eye Exam Includes
Dilated Fundoscopy
Drops widen the pupil so the back of the eye can be examined with a slit lamp, indirect ophthalmoscope, and lenses. The retina, optic nerve, macula, and blood vessels are inspected for microaneurysms, hemorrhages, hard exudates, cotton-wool spots, venous beading, intraretinal microvascular abnormalities, neovascularization, and tractional changes.
Optical Coherence Tomography (OCT)
A noncontact imaging technique that produces cross-section views of the retina at near-cellular resolution. OCT is the gold standard for detecting and quantifying diabetic macular edema and is the metric used to track response to anti-VEGF therapy. The test takes only a few minutes and does not require injection or dilation in many machines.
Fluorescein Angiography
A yellow dye is injected into an arm vein and a rapid series of photos captures it flowing through the retinal vessels. The test highlights areas of leakage, capillary non-perfusion, and neovascularization. It is used selectively for surgical planning and severe cases. Side effects include transient yellow skin tinge, yellow urine for a day, mild nausea, and rarely allergic reactions.
Optical Coherence Tomography Angiography (OCTA)
A newer dye-free imaging that shows retinal vasculature in detail. Increasingly used in routine retina practice.
Ultra-Widefield Imaging
Camera systems that capture 200 degrees of the retina in a single image, useful for screening, monitoring peripheral pathology, and teleretinal screening programs.
Stages of Diabetic Retinopathy and Specialist Involvement
| Stage | What the Specialist Sees | Typical Action |
|---|---|---|
| No retinopathy | Healthy retina | Re-exam in 1–2 years |
| Mild NPDR | Microaneurysms only | Re-exam in 6–12 months |
| Moderate NPDR | Hemorrhages, hard exudates, mild venous beading | Re-exam in 3–6 months; OCT if macular edema suspected |
| Severe NPDR | Extensive hemorrhages or microvascular abnormalities | Close monitoring; consider early treatment to reduce progression risk |
| Proliferative DR (PDR) | New fragile vessels on the retina or disc | Anti-VEGF or panretinal photocoagulation |
| Diabetic macular edema | Macular thickening on OCT | Anti-VEGF injections, sometimes focal laser or steroid implant |
| Vitreous hemorrhage or tractional detachment | Bleeding into the vitreous; pulling on the retina | Pars plana vitrectomy |
Treatments — A Closer Look
Anti-VEGF Injections
Vascular endothelial growth factor is the molecular driver of both neovascularization and macular leakage in diabetes. Anti-VEGF drugs block it. Current options include:
- Aflibercept (Eylea, Eylea HD): common first-line for DME; 8-mg high-dose formulation extends dosing intervals
- Ranibizumab (Lucentis): the original FDA-approved anti-VEGF for DME and PDR
- Bevacizumab (Avastin): off-label but widely used, generally lower cost
- Faricimab (Vabysmo): dual VEGF and Ang-2 inhibitor, may extend treatment intervals
- Brolucizumab (Beovu): approved for DME with extended dosing in some patients
Injections are usually given monthly at first, with intervals extended as the macula responds. Many people require ongoing periodic injections for years; treatment burden is a real consideration to discuss with the specialist.
Laser Photocoagulation
- Panretinal photocoagulation (PRP): hundreds of laser burns to the peripheral retina shrink fragile new vessels in proliferative disease. Side effects can include reduced peripheral and night vision.
- Focal/grid laser: targeted application near leaking microaneurysms in macular edema, used less often now that anti-VEGF is mainstay but still has a role.
Intravitreal Corticosteroids
Dexamethasone implants (Ozurdex) and fluocinolone implants (Iluvien) deliver sustained steroid release for chronic or recurrent DME. Side effects include cataract progression and elevated eye pressure.
Pars Plana Vitrectomy
Surgery removes the vitreous gel to clear non-clearing vitreous hemorrhage, repair tractional retinal detachment, peel epiretinal membranes, and treat severe PDR not responsive to other therapy. Performed by vitreoretinal surgeons.
Cost, Insurance, and Practical Tips
- Anti-VEGF injections are covered by most insurance for diabetic eye disease, but copays per visit can add up. Patient assistance programs are available from manufacturers.
- Bevacizumab is the most cost-effective option in many settings and is often used first.
- Confirm the specialist accepts your insurance and whether they perform injections in-office (typical) or require an ambulatory surgery center.
- Bring a list of all medications, including the specific names and doses of diabetes treatments.
- Arrange transportation home if dilation drops are used — driving is uncomfortable for several hours after dilation.
- Bring sunglasses; the eye will be light-sensitive for the rest of the exam day.
What You Can Do Between Visits
- Keep A1C and blood pressure as steady as possible — avoid rapid swings in glucose, which can transiently worsen retinopathy.
- Stop smoking.
- Manage cholesterol; statins are associated with lower retinopathy progression.
- Use an Amsler grid at home as instructed to monitor for distortion in central vision.
- Report new floaters, flashes, or vision loss promptly.
- For broader context, see our overviews of diabetes complications and treatment.
For authoritative reading, see the American Academy of Ophthalmology’s diabetic retinopathy guidance and the National Eye Institute.
Finding a Diabetic Retinopathy Specialist
- Ask your endocrinologist or primary care doctor for a referral
- Use the American Academy of Ophthalmology’s “Find an Ophthalmologist” tool
- Look for retina-trained ophthalmologists at academic medical centers
- Check insurance directories for in-network retina specialists
- Telemedicine and AI-based retinal screening tools are increasingly available in primary care and pharmacy settings for initial detection
The Bottom Line
A diabetic retinopathy specialist is most often a retina-trained ophthalmologist who handles the imaging, injections, laser treatments, and surgeries that protect vision in diabetes. The American Diabetes Association and American Academy of Ophthalmology both recommend dilated screening at diagnosis (type 2), within 5 years (type 1), and at least every 1 to 2 years thereafter — more often if retinopathy is found or during pregnancy. Anti-VEGF injections have transformed outcomes for diabetic macular edema and proliferative retinopathy; laser and vitrectomy remain critical for advanced disease. The biggest leverage remains prevention: steady glucose, blood pressure, and lipid control, plus on-time exams. Talk to your eye care provider about the right screening interval and specialist referral for your situation.
